2026-2034年全球醫療設備分析測試外包市場規模、佔有率、趨勢和成長分析報告

預計醫療設備分析測試外包市場規模將從 2025 年的 88.8 億美元成長到 2034 年的 235.2 億美元，2026 年至 2034 年的複合年成長率為 11.43%。

全球醫療設備分析測試外包市場正經歷強勁成長，製造商越來越依賴第三方服務供應商來確保產品安全、品質和合規性。分析測試在檢驗儀器性能、生物相容性和材料完整性方面發揮著至關重要的作用。隨著醫療設備日益複雜，監管要求也日益嚴格，外包正成為企業精簡營運、降低成本的策略選擇。

關鍵促進因素包括對先進醫療設備需求的成長、監管力度的加強以及加快產品核可的需求。外包使企業無需大量資本投入即可獲得專業知識、先進的測試技術和經認證的實驗室。此外，全球醫療保健產業的擴張以及研發活動的活性化也推動了市場成長。

隨著自動化、數位化測試平台和人工智慧分析技術的引入，市場預計未來將顯著成長。個人化醫療設備和穿戴式科技的發展趨勢將進一步提升測試需求。隨著法律規範的不斷演變，外包分析測試對於確保合規性和加速創新仍將至關重要。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球醫療設備分析測試外包市場：依器材類型分類

• 市場分析、洞察與預測
• 再加工醫療設備
• 其他設備類型

第5章：全球醫療設備分析測試外包市場：依分析類型分類

• 市場分析、洞察與預測
• SNP分析
• 突變分析
• 微陣列分析
• RNA干擾
• 其他

第6章：全球醫療設備分析測試外包市場：依服務類型分類

• 市場分析、洞察與預測
• 萃取物和洗脫液
• 材料性能評價
• 實體測試
• 微生物附著量測試
• 無菌測試
• 其他服務

第7章：全球醫療設備分析測試外包市場：依治療領域分類

• 市場分析、洞察與預測
• 循環系統
• 診斷影像
• 整形外科
• IVD
• 眼科
• 一般外科和整形外科
• 藥物輸送
• 內視鏡檢查
• 牙科
• 糖尿病護理
• 其他治療領域

第8章：全球醫療設備分析測試外包市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 其他用途

第9章：全球醫療設備分析測試外包市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • SGS SA
  • Toxikon Inc
  • Eurofins Scientific SE
  • Pace Analytical Services LLC
  • Intertek Group Plc
  • WuXi AppTec
  • North American Science Associates Inc
  • Envigo
  • Charles River Laboratories International Inc
  • Medical Device Testing Services

The Medical Device Analytical Testing Outsourcing Market size is expected to reach USD 23.52 Billion in 2034 from USD 8.88 Billion (2025) growing at a CAGR of 11.43% during 2026-2034.

The global medical device analytical testing outsourcing market is experiencing strong growth as manufacturers increasingly rely on third-party service providers to ensure product safety, quality, and regulatory compliance. Analytical testing plays a critical role in validating device performance, biocompatibility, and material integrity. With the growing complexity of medical devices and stricter regulatory requirements, outsourcing has become a strategic approach for companies aiming to streamline operations and reduce costs.

Key drivers include the rising demand for advanced medical devices, increasing regulatory scrutiny, and the need for faster product approvals. Outsourcing enables companies to access specialized expertise, advanced testing technologies, and certified laboratories without heavy capital investment. Additionally, the expansion of the global healthcare sector and increasing R&D activities are further supporting market growth.

Looking ahead, the market is expected to grow significantly with the adoption of automation, digital testing platforms, and AI-driven analysis. The trend toward personalized medical devices and wearable technologies will further increase testing requirements. As regulatory frameworks continue to evolve, outsourcing analytical testing will remain essential for ensuring compliance and accelerating innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

• Reprocessed Devices
• Other Device Types

By Analysis Type

• Snp Analysis
• Mutational Analysis
• Microarray Analysis
• Rna Interference
• Others

By Service

• Extractable And Leachable
• Material Characterization
• Physical Testing
• Bioburden Testing
• Sterility Testing
• Other Services

By Therapeutic Areas

• Cardiology
• Diagnostic Imaging
• Orthopedic
• Ivd
• Ophthalmic
• General & Plastic Surgery
• Drug Delivery
• Endoscopy
• Dental
• Diabetes Care
• Other Therapeutic Areas

By End-Use

• Hospital
• Other End-Uses

COMPANIES PROFILED

• SGS SA, Toxikon Inc, Eurofins Scientific SE, Pace Analytical Services LLC, Intertek Group plc, WuXi AppTec, North American Science Associates Inc, Envigo, Charles River Laboratories International Inc, Medical Device Testing Services
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Device Type
• 4.2. Reprocessed Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Other Device Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET: BY ANALYSIS TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Analysis Type
• 5.2. Snp Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Mutational Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Microarray Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Rna Interference Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET: BY SERVICE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Service
• 6.2. Extractable And Leachable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Material Characterization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Physical Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Bioburden Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Sterility Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET: BY THERAPEUTIC AREAS 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Therapeutic Areas
• 7.2. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Orthopedic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Ivd Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Ophthalmic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. General & Plastic Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.8. Drug Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.9. Endoscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.10. Dental Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.11. Diabetes Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.12. Other Therapeutic Areas Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Other End-Uses Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Device Type
  • 9.2.2 By Analysis Type
  • 9.2.3 By Service
  • 9.2.4 By Therapeutic Areas
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Device Type
  • 9.3.2 By Analysis Type
  • 9.3.3 By Service
  • 9.3.4 By Therapeutic Areas
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Device Type
  • 9.4.2 By Analysis Type
  • 9.4.3 By Service
  • 9.4.4 By Therapeutic Areas
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Device Type
  • 9.5.2 By Analysis Type
  • 9.5.3 By Service
  • 9.5.4 By Therapeutic Areas
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Device Type
  • 9.6.2 By Analysis Type
  • 9.6.3 By Service
  • 9.6.4 By Therapeutic Areas
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL MEDICAL DEVICE ANALYTICAL TESTING OUTSOURCING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 SGS S.A
  • 11.2.2 Toxikon Inc
  • 11.2.3 Eurofins Scientific SE
  • 11.2.4 Pace Analytical Services LLC
  • 11.2.5 Intertek Group Plc
  • 11.2.6 WuXi AppTec
  • 11.2.7 North American Science Associates Inc
  • 11.2.8 Envigo
  • 11.2.9 Charles River Laboratories International Inc
  • 11.2.10 Medical Device Testing Services